Arnatar announces publication of key patents for ACT-UP1, a first-in-class #antisense platform to #upregulate protein expression. A breakthrough for #haploinsufficient & #ProteinDeficiency diseases.

🧬 Learn more: https://bit.ly/41JBRDE